Thermo Fisher Scientific has entered into a strategic partnership with HealthVerity, a leader in real-world data platforms, to expand the use of real world evidence (RWE) in clinical research. The collaboration will enable researchers and life sciences companies to access de-identified, privacy compliant patient data from millions of records, accelerating drug development, clinical trial design, and post market studies.
Glimpse:
The partnership combines Thermo Fisher’s extensive laboratory and clinical data capabilities with HealthVerity’s secure data ecosystem and identity resolution technology. This will allow for more precise linking of disparate healthcare datasets, delivering richer insights into patient outcomes, treatment effectiveness, and disease patterns while maintaining strict data privacy and regulatory compliance.
Thermo Fisher Scientific and HealthVerity have announced a major collaboration aimed at unlocking the full potential of real world data in clinical research and drug development. The partnership will help pharmaceutical companies, researchers, and healthcare organisations better utilise real-world evidence to make faster, more informed decisions throughout the product lifecycle.
HealthVerity’s platform provides secure access to one of the largest de-identified healthcare datasets in the US, covering medical, pharmacy, and lab claims from millions of patients. By integrating this with Thermo Fisher’s scientific expertise and laboratory data, the two companies aim to create more comprehensive, longitudinal patient views that can support everything from early stage research and trial optimisation to post approval safety monitoring and personalised medicine initiatives.
This alliance is expected to significantly improve the speed and quality of real world studies, reduce costs associated with traditional clinical trials, and help bring new therapies to market more efficiently.
“Real world data is becoming indispensable for modern clinical research. Our partnership with HealthVerity will empower our customers with deeper, more actionable insights while maintaining the highest standards of data privacy and scientific rigor.”
By
HB Team
